Using genetic risk and shared decision-making to guide cancer screening

Building a shared decision making implementation strategy for the emerging paradigm of precision cancer screening

NIH-funded research Edith Nourse Rogers Memorial Veterans Hospital · NIH-11222667

This project builds tools to help people and their clinicians use genetic risk scores and shared decision-making to decide if and when to have cancer screening.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionEdith Nourse Rogers Memorial Veterans Hospital NIH-funded
Lab location1 site (Bedford, United States)
Project IDNIH-11222667 on NIH RePORTER

What this research studies

You would be offered new tools and clear conversations that combine genetic risk scores with information about the benefits and harms of screening. The team will work with clinicians and clinics to design training, patient materials, and workflows that support these conversations in real-world care. The effort focuses on making it practical for providers to present personalized risk and for patients to share their values and preferences. The aim is to fit genetic risk information into routine screening decisions without adding confusion or extra tests.

Who could benefit from this research

Good fit: People facing routine cancer screening decisions—especially men considering PSA testing or anyone who has genetic risk information—would be typical candidates.

Not a fit: Patients who are not eligible for routine screening, who need immediate diagnostic or treatment care, or who do not want genetic information are unlikely to benefit.

Why it matters

Potential benefit: If successful, this could lead to more personalized screening choices that reduce unnecessary tests and treatments while focusing screening on people at higher genetic risk.

How similar studies have performed: Shared decision-making has helped with screening choices before, but combining it with polygenic risk scores is a newer approach that is still being tested.

Where this research is happening

Bedford, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Breast CancerBreast Cancer 2 GeneBreast Cancer Type 2 Susceptibility GeneCancer CenterCancers
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.